Pluristem Files Patent Application For Expanding Hematopoeitic Stem Cells (HSC) and Early Progenitor Cells from Cord Blood Non Selected Mono-Nuclear Cells (MNC)

Pluristem Life Systems, Inc. (OTC BB:PLRS - News today announced that a patent application has been filed with the US Patent and Trademark Office for a new procedure for expanding Hematopoeitic Stem Cells (HSC) and early progenitor cells from Cord blood from non selected mono-nuclear cells (MNC) of the cord blood.

Source: Pluristem Life Systems, Inc.